Tumor necrosis factor receptor deletion reduces nuclear factor-κB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury

Journal of Neuroscience

Volumn 21, Issue 17, 2001, Pages 6617-6625

  Kim, Gyeong Moon ^a   Xu, Jan ^a   Xu, Jinming ^a   Song, Sheng Kwei ^b   Yan, Ping ^c   Ku, Grace ^a   Xu, Xiao Ming ^c   Hsu, Chung Y ^a,d  

^a Department of Neurology   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase 3; Cytokine; TNFR1; TNFR2; Tumor necrosis factor

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONVALESCENCE; FEMALE; GENE DELETION; GENE EXPRESSION; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY;

EID: 0035449479     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-17-06617.2001     Document Type: Article

References (86)

1. Expression of c-fos and c-jun family genes after focal cerebral ischemia
2. Function and activation of NF-κB in the immune system
3. The NF-κB and I-κB proteins: New discoveries and insights
4. Nuclear factor-κB
5. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
6. Tumor necrosis factor-α. A mediator of focal ischemic brain injury
7. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse, an in situ hybridization study
8. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weightdrop device versus transection
9. MASCIS evaluation of open field locomotor scores: Effects of experience and teamwork on reliability. Multicenter animal spinal cord injury study
10. Endogenous repair after spinal cord contusion injuries in the rat
11. An essential role for NF-κB in preventing TNF-α-induced cell death
12. Traumatic spinal cord injury induces nuclear factor-κB activation
13. Spatial and temporal evolution of hemorrhage in the hyperacute phase of experimental spinal cord injury: In vivo magnetic resonance imaging
14. Morphometric analysis of experimental spinal cord injury in the cat: The relation of injury intensity to survival of myelinated axons
15. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
16. L
17. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control
18. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys
19. X-linked IAP is a direct inhibitor of cell-death proteases
20. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
21. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
22. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury
23. A conserved family of cellular genes related to the baculovirus IAP gene and encoding apoptosis inhibitors
24. Decreased sensitivity to tumor necrosis factor but normal T-cell development in TNF receptor-2-deficient mice
25. Improved recovery after spinal cord injury in neuronal nitric oxide synthase-deficient mice but not in TNF-α-deficient mice
26. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor
27. Regulation of inducible gene expression by the transcription factor NF-κB
28. Differential effects of BDNF, ADN F9, and TNF-α on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity
29. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation
30. A monitored contusion model of spinal cord injury in the rat
31. Postmortem magnetic resonance imaging of experimental spinal cord injury: Magnetic resonance findings versus in vivo functional deficit
32. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia
33. Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmunemediated demyelination
34. Involvement of two NF-κB binding elements in tumor necrosis factor α-, CD40-, and Epstein-Barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene
35. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
36. Traumatic spinal cord injury produced by controlled contusion in mouse
37. Induction and its spread of apoptosis in rat spinal cord after mechanical trauma
38. Effects of pro-inflammatory cytokines in experimental spinal cord injury
39. A mouse model of graded contusive spinal cord injury
40. The apoptotic cysteine protease CPP32
41. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-κB site and p65 homodimers
42. NF-κB, a pleiotropic mediator of inducible and tissue-specific gene control
43. Apoptosis and expression of Bcl-2 after compression trauma to rat spinal cord
44. Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury
45. Expression of tumor necrosis factor receptor (TNF-R) and nuclear factor-κB (NF-κB) in adult rats following traumatic spinal cord injury
46. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes
47. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
48. Neuronal and glial apoptosis after traumatic spinal cord injury
49. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death
50. Roles of nuclear factor-κB in neuronal survival and plasticity
51. N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro
52. TNF-α pretreatment induces protective effects against focal cerebral ischemia in mice
53. Experimental study on MRI evaluation of the course of cervical spinal cord injury
54. NF-κB: A crucial transcription factor for glial and neuronal cell function
55. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor-α
56. Cooperative signaling by tumor necrosis factor receptors CD120a (p55) and CD120b (p75) in the expression of nitric oxide and inducible nitric oxide synthase by mouse macrophages
57. Quantitative analysis of acute axonal pathology in experimental spinal cord contusion
58. Xenotransplantation of transgenic oligodendrocyte-lineage cells into spinal cord-injured adult rats
59. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
60. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
61. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
62. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury
63. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells
64. Involvement of a NF-κB-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines
65. Inhibition of tumor necrosis factor α (TNFα) activity in rat brain is associated with cerebroprotection after closed head injury
66. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats
67. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
68. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury
69. Exacerbation of damage and altered NF-κB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury
70. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NF-κB activation in primary hippocampal neurons
71. Ligand passing: The 75 kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55 kDa TNF receptor
72. Update on the pathophysiology and pathology of acute spinal cord injury
73. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptorassociated factors
74. Suppression of TNF-α-induced apoptosis by NF-κB
75. Production of tumor necrosis factor in spinal cord following traumatic injury in rats
76. NF-κB anti-apoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
77. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors
78. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosomelinked inhibitor of apoptosis protein overexpression in the rat hippocampus
79. Amyloid-β peptides are cytotoxic to oligodendrocytes
80. Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury
81. Methylprednisolone inhibition of TNF-α expression and NF-κB activation after spinal cord injury in rats
82. Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein
83. Sequential expression of c-fos protooncogene, TNF-α, and dynorphin gene in spinal cord following experimental traumatic injury
84. Glucocorticoid receptor expression in the spinal cord after traumatic injury in adult rats
85. Inhibition of TNFα attenuates infarct volume and ICAM-1 expression in ischemic mouse brain
86. Lack of the p50 subunit of nuclear factor-κB increases the vulnerability of hippocampal neurons to excitotoxic injury